|Min SIP Amount||₹500|
|NAV||₹9.43 (25 Sep 2020)|
|Fund Started||28 Jun 2018|
|Fund Size||₹631 Cr|
|Divi's Laboratories Ltd.||Healthcare||Equity||5.4%|
|Avenue Supermarts Ltd.||Services||Equity||4.5%|
|SBI Life Insurance Company Ltd.||Financial||Equity||4.4%|
|Dabur India Ltd.||FMCG||Equity||3.6%|
|ICICI Lombard General Insurance Company Ltd.||Financial||Equity||3.4%|
|Godrej Consumer Products Ltd.||FMCG||Equity||3.4%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||3.1%|
|Info Edge (India) Ltd.||Services||Equity||3.1%|
|Pidilite Industries Ltd.||Chemicals||Equity||2.9%|
UTI Nifty Next 50 Index Fund Regular Growth is a Equity Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 28 Jun 2018. Kaushik Basu, Sharwan Kumar Goyal is the Current Fund Manager of UTI Nifty Next 50 Index Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹631 Cr and the Latest NAV as of 25 Sep 2020 is ₹9.43.
The UTI Nifty Next 50 Index Fund Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000.
The scheme seeks to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.